CSL Limited
ASX: CSL
CSL Ltd. is a global biopharmaceutical company involved in the production, marketing, and distribution of biotechnology and related healthcare products. The business operates through three key segments: CSL Behring, CSL Seqirus, and CSL Vifor. The CSL Behring division develops and supplies plasma-derived therapies, recombinant products, and gene therapies
🔒
Subscribers only
Sign in with your subscriber account or subscribe to access this research report.
Required subscription
Healthcare Pulse Report
A$1200.00
Already a subscriber?
Sign in to read this report.
Required subscription
Healthcare Pulse Report
Stay informed on Australia's healthcare sector with expert research covering healthcare, biotechnology, medical technology, and life sciences companies listed on the ASX.
- ✓ ASX Healthcare & Biotech Research
- ✓ Delivered Fortnightly every 2nd & 4th Tuesday
- ✓ Industry Trends & Risk Analysis
- ✓ Full Historical Report Access
A$1200.00/ 12 months
Risk:High
Subscribe Now →
